Published on 14/05/2021 11:02:05 AM | Source: Dion Global Solutions Ltd

Eris Lifesciences Q4 net profit up 27.06% at Rs 69.35 cr

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

The company reported standalone net profit of Rs 69.35 crore for the quarter ended March 31, 2021 as compared to Rs 54.58 crore in the same period last year, registering a year-on-year growth of 27.06 per cent. Net revenue of the company rose moderately by 13.61 per cent at Rs 256.85 crore in January-March quarter of this fiscal as against Rs 226.08 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 3.31 per cent to Rs 162.83 crore from Rs 157.61 crore in year ago period. Other Income grew by 443.75 per cent at Rs 2.75 crore versus (Mar'20 Rs -0.80 crore).

Operating Profit surged by 28.57 per cent to Rs 94.02 crore as against Rs 73.13 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 13.17 per cent in March quarter. Interest declined by 23.08 per cent y-o-y to Rs 0.20 crore, while Taxation increased by 279.56 per cent at Rs 17.08 crore (Mar'20 Rs 4.50 crore).